Bio Protech Statistics

Total Valuation

Bio Protech has a market cap or net worth of KRW 7.20 billion.

Market Cap	7.20B
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Bio Protech has 14.47 million shares outstanding.

Current Share Class	14.47M
Shares Outstanding	14.47M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	27.53%
Owned by Institutions (%)	2.94%
Float	6.31M

Valuation Ratios

The trailing PE ratio is 2.50.

PE Ratio	2.50
Forward PE	n/a
PS Ratio	0.35
PB Ratio	0.47
P/TBV Ratio	0.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.13, with a Debt / Equity ratio of 1.17.

Current Ratio	1.13
Quick Ratio	0.59
Debt / Equity	1.17
Debt / EBITDA	7.31
Debt / FCF	-22.75
Interest Coverage	1.49

Financial Efficiency

Return on equity (ROE) is 3.72% and return on invested capital (ROIC) is 2.45%.

Return on Equity (ROE)	3.72%
Return on Assets (ROA)	2.13%
Return on Invested Capital (ROIC)	2.45%
Return on Capital Employed (ROCE)	5.96%
Revenue Per Employee	190.54M
Profits Per Employee	5.12M
Employee Count	108
Asset Turnover	0.55
Inventory Turnover	1.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.83% in the last 52 weeks. The beta is -0.47, so Bio Protech's price volatility has been lower than the market average.

Beta (5Y)	-0.47
52-Week Price Change	-28.83%
50-Day Moving Average	523.36
200-Day Moving Average	535.29
Relative Strength Index (RSI)	51.80
Average Volume (20 Days)	3,467

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bio Protech had revenue of KRW 20.58 billion and earned 552.54 million in profits. Earnings per share was 199.00.

Revenue	20.58B
Gross Profit	4.14B
Operating Income	1.27B
Pretax Income	552.54M
Net Income	552.54M
EBITDA	2.45B
EBIT	1.27B
Earnings Per Share (EPS)	199.00

Balance Sheet

The company has 277.70 million in cash and 17.93 billion in debt, giving a net cash position of -17.66 billion or -1,220.56 per share.

Cash & Cash Equivalents	277.70M
Total Debt	17.93B
Net Cash	-17.66B
Net Cash Per Share	-1,220.56
Equity (Book Value)	15.37B
Book Value Per Share	5,221.38
Working Capital	2.24B

Cash Flow

In the last 12 months, operating cash flow was -3.89 million and capital expenditures -784.31 million, giving a free cash flow of -788.20 million.

Operating Cash Flow	-3.89M
Capital Expenditures	-784.31M
Free Cash Flow	-788.20M
FCF Per Share	-54.49

Margins

Gross margin is 20.10%, with operating and profit margins of 6.18% and 2.69%.

Gross Margin	20.10%
Operating Margin	6.18%
Pretax Margin	2.69%
Profit Margin	2.69%
EBITDA Margin	11.93%
EBIT Margin	6.18%
FCF Margin	n/a

Dividends & Yields

Bio Protech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	7.67%
FCF Yield	-10.94%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Bio Protech has an Altman Z-Score of 0.74 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.74
Piotroski F-Score	2